common dosage ghk-cu peptide and Protocol: A Medical Provider's Guide to the 30-Day Cycle GHK-Cu Dosage: Clinical Guidance for
Description
Scientific Reports 8:3660
Kuang, R., Levinthal, D
Homocysteine and cardiovascular disease Observational studies indicate that even moderately elevated blood concentrations of homocysteine raise the risk of cardiovascular disease (CVD), although randomized controlled trials of homocysteine-lowering therapy have generally not translated to reductions in adverse cardiovascular outcomes (26, 27)
Clinical studies demonstrated a 28% reduction in overall mortality over a 12-year period with Epitalon treatment compared to the control group.
